Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis

Published:2018-05-08 Issue:10 Volume:97 Page:2005-2008
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Molica Stefano^ORCID,Giannarelli Diana,Mirabelli Rosanna,Levato Luciano,Shanafelt Tait D.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-018-3350-5/fulltext.html

Reference13 articles.

1. International CLL-IPI working group (2016) An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol 17(6):779–790

2. Gentile M, Shanafelt TD, Rossi D, Laurenti L, Mauro FR, Molica S, Cutrona G, Uccello G, Campanelli M, Vigna E, Tripepi G, Chaffee KG, Parikh SA, Bossio S, Recchia AG, Innocenti I, Pasquale R, Neri A, Ferrarini M, Gaidano G, Foa R, Morabito F (2016) Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients. Blood 128(16):2093–2095

3. da Cunha-Bang C, Christiansen I, Niemann CU (2016) The CLL-IPI applied in a population-based cohort. Blood 128(17):2181–2183

4. Goede V, Bahlo J, Kutsch N et al (2016) Evaluation of the International prognostic index for chronic lymphocytic leukemia (CLL-IPI) in elderly patients with comorbidities: analysis of the CLL11 study population. Blood 128:4401

5. Ferrer Lores B, Navarro Cubells B, Serrano Alcala A et al (2016) Prognostic impact of the new CLL-IPI Index in a single center CLL Spanish cohort. Blood 128:2019

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Prognostic Models Should We Use in CLL?;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia;Annals of Hematology;2024-02-03

3. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia;Annals of Hematology;2023-11-09

4. The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When;Cancers;2023-09-02

5. Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience;Hematological Oncology;2023-02-17